Steven Kronlage, MD
Orthopaedic Surgery · Gulf Breeze, FLNPI 1861585986
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $100,291 of the $102,883 with a category attached, or 97.5%. Arthrex accounts for 98.2% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $24,445 and has fallen 97.9% since, to $517 in 2025.
Across 41 payments — averaging $2509.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$101K
- CGG Medical Inc$1K
- Bioventus LLC$200
- Stryker$127
- DJO, LLC$44
- Johnson & Johnson$20
- plus $50 from 3 others
What the payments were for
- Royalty or licence$100,29197%
- Travel & lodging$2530%
- Food & beverage$7421%
- Education$1,5972%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 24 | $101,016 |
| CGG Medical Inc | 3 | $1,427 |
| Bioventus LLC | 7 | $200 |
| Stryker | 2 | $127 |
| DJO, LLC | 1 | $44 |
| Johnson & Johnson | 1 | $20 |
| Orthofix Medical, Inc. | 1 | $18 |
| Stimwave Technologies Incorporated | 1 | $17 |
| CSL Behring | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARTHREX$148,443
- DISTAL EXTREMITIES INSTRUMENTS HAND & WRIST OTHER$20,573
- DISTAL EXTREMITIES IMPLANTS HAND & WRIST MINI TIGHTROPES$20,573
- EXTREMITIES & TRAUMA INSTRUMENTS SOFT TISSUE$6,648
- DISTAL EXTREMITIES INSTRUMENTS SOFT TISSUE OTHER$5,496
- DISTAL EXTREMITIES IMPLANTS SOFT TISSUE H&W MINI TIGHTROPES$5,496
How this compares
$102,883 in reported general payments places this provider in the 85th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 137 | $1,263 |
| Minocycline Hcl | 19 | $195 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $189 |
| Methylprednisolone | 12 | $49 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $42 |
| Tramadol Hcl | 11 | $22 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Gulf Breeze
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$34.8M
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
- Robert SantrockFernandina Beach$7.3M
- Martin RocheFt. Lauderdale$7.1M
- Steven LyonsTampa$6.7M
- Thomas BernasekTemple Terrace$6.4M
- Bryan SpringerJacksonville$6.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.